{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:12:06Z","timestamp":1792548726201,"version":"4.5.0"},"reference-count":163,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.semnephrol.2018.02.007","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T22:26:49Z","timestamp":1525904809000},"page":"277-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Clinical Studies of Interventions to Mitigate Cardiovascular Risk in Peritoneal Dialysis Patients"],"prefix":"10.1016","volume":"38","author":[{"given":"Dev","family":"Jegatheesan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeoungjee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2018.02.007_bib1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2369-13-94","article-title":"China collaborative study on dialysis: a multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysis","volume":"13","author":"Hou","year":"2012","journal-title":"BMC Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2018.02.007_bib3","article-title":"United States Renal Data System 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States","volume":"59","author":"Collins","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.ajkd.2011.01.024","article-title":"Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population","volume":"58","author":"Roberts","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib5","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/jama.2009.1488","article-title":"Cardiovascular and noncardiovascular mortality among patients starting dialysis","volume":"302","author":"de Jager","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib6","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2215\/CJN.01750309","article-title":"Association of dialysis modality and cardiovascular mortality in incident dialysis patients","volume":"4","author":"Johnson","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2018.02.007_bib7","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1177\/089686080702702s35","article-title":"Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis","volume":"27","author":"Garcia-Lopez","year":"2007","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib8","doi-asserted-by":"crossref","first-page":"909373","DOI":"10.1155\/2014\/909373","article-title":"Clinical causes of inflammation in peritoneal dialysis patients","volume":"2014","author":"Cho","year":"2014","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib9","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2215\/CJN.00960112","article-title":"Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort","volume":"7","author":"Torlen","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib10","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.2012100987","article-title":"Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients","volume":"24","author":"Li","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.ajkd.2007.01.018","article-title":"New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis","volume":"49","author":"Szeto","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000153248","article-title":"Initiation of glucose-based peritoneal dialysis is associated with increased prevalence of metabolic syndrome in non-diabetic patients with end-stage renal disease","volume":"26","author":"Jiang","year":"2008","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1440-1797.2007.00804.x","article-title":"Metabolic syndrome in severe chronic kidney disease: prevalence, predictors, prognostic significance and effects of risk factor modification","volume":"12","author":"Johnson","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib14","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/ndt\/gfp498","article-title":"Metabolic syndrome predicts mortality in non-diabetic patients on continuous ambulatory peritoneal dialysis","volume":"25","author":"Park","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib15","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1093\/ndt\/gfr175","article-title":"Associations of metabolic syndrome and its components with cardiovascular outcomes among non-diabetic patients undergoing maintenance peritoneal dialysis","volume":"26","author":"Liao","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2018.02.007_bib16","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.17305\/bjbms.2010.2638","article-title":"The metabolic syndrome in patients on peritoneal dialysis: prevalence and influence on cardiovascular morbidity","volume":"10","author":"Rasic","year":"2010","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib17","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/ndt\/14.6.1536","article-title":"Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study","volume":"14","author":"Cocchi","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jash.2011.02.004","article-title":"Hypertension in peritoneal dialysis patients: epidemiology, pathogenesis, and treatment","volume":"5","author":"Ortega","year":"2011","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2215\/CJN.08180814","article-title":"Ambulatory recording of wave reflections and arterial stiffness during intra- and interdialytic periods in patients treated with dialysis","volume":"10","author":"Karpetas","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib20","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1053\/ajkd.2001.29221","article-title":"Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses","volume":"38","author":"Agarwal","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib21","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","article-title":"Sympathetic overactivity in patients with chronic renal failure","volume":"327","author":"Converse","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib22","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1161\/01.CIR.0000034043.16664.96","article-title":"Sympathetic nerve activity in end-stage renal disease","volume":"106","author":"Hausberg","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1440-1797.2012.01659.x","article-title":"Role of asymmetrical dimethylarginine in the progression of renal disease","volume":"18","author":"Raptis","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.ASN.0000106717.58091.F6","article-title":"Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease","volume":"15","author":"Mallamaci","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib25","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2215\/CJN.08760914","article-title":"Obstructive sleep apnea severity and overnight body fluid shift before and after hemodialysis","volume":"10","author":"Ogna","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib26","first-page":"E642","article-title":"Influence of recombinant human erythropoietin on blood pressure and tissue renin-angiotensin systems","volume":"261","author":"Eggena","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.semnephrol.2014.08.008","article-title":"Erythropoietin and resistant hypertension in CKD","volume":"34","author":"Boyle","year":"2014","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.ajkd.2008.08.030","article-title":"Blood pressure and mortality risk on peritoneal dialysis","volume":"53","author":"Udayaraj","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib29","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1046\/j.1523-1755.1999.00353.x","article-title":"Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group","volume":"55","author":"Jager","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3747\/pdi.2014.00279","article-title":"ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part I - assessment and management of various cardiovascular risk factors","volume":"35","author":"Wang","year":"2015","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib31","first-page":"163","article-title":"Genesis and control of hypertension in hemodialysis patients","volume":"8","author":"Zucchelli","year":"1988","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib32","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1525-139X.2009.00641.x","article-title":"Can chronic volume overload be recognized and prevented in hemodialysis patients? The pitfalls of the clinical examination in assessing volume status","volume":"22","author":"Sinha","year":"2009","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1525-139X.2003.16070.x","article-title":"Sodium balance in hemodialysis therapy","volume":"16","author":"Kooman","year":"2003","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib34","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/ndt\/gfn668","article-title":"The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status","volume":"24","author":"Davies","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib35","first-page":"862","article-title":"Angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker use and cardiovascular outcomes in patients initiating peritoneal dialysis","volume":"32","author":"Shen","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-139-2-200307150-00010","article-title":"Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study","volume":"139","author":"Li","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib37","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1681\/ASN.2013030273","article-title":"Long-term effects of spironolactone in peritoneal dialysis patients","volume":"25","author":"Ito","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/ndt\/gfp395","article-title":"NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients","volume":"25","author":"Paniagua","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib39","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/ndt\/gfn707","article-title":"The mortality risk of overhydration in haemodialysis patients","volume":"24","author":"Wizemann","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib40","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/ndt\/gfv013","article-title":"Baseline hydration status in incident peritoneal dialysis patients: the initiative of patient outcomes in dialysis (IPOD-PD study)dagger","volume":"30","author":"Ronco","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib41","doi-asserted-by":"crossref","first-page":"e53294","DOI":"10.1371\/journal.pone.0053294","article-title":"Prevalence and risk factors of fluid overload in Southern Chinese continuous ambulatory peritoneal dialysis patients","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib42","first-page":"5890","article-title":"The impact of sub-clinical over-hydration on left ventricular mass in peritoneal dialysis patients","volume":"8","author":"Hassan","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib43","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1093\/ndt\/gfs116","article-title":"Chest ultrasound and hidden lung congestion in peritoneal dialysis patients","volume":"27","author":"Panuccio","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib44","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/ndt\/gfu049","article-title":"Clinical significance of multi-frequency bioimpedance spectroscopy in peritoneal dialysis patients: independent predictor of patient survival","volume":"29","author":"O'Lone","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/089686080602600113","article-title":"Volume control associated with better cardiac function in long-term peritoneal dialysis patients","volume":"26","author":"Asci","year":"2006","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib46","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1046\/j.1523-1755.2003.00887.x","article-title":"Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study","volume":"63","author":"Konings","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib47","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1097\/01.ASN.0000083904.12234.27","article-title":"Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial","volume":"14","author":"Davies","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib48","article-title":"Biocompatible dialysis fluids for peritoneal dialysis","volume":"3","author":"Cho","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib49","series-title":"Global Kidney Health Atlas: a report by the International Society of Nephrology on the current state of organization and structures for kidney care across the globe","author":"Bello","year":"2017"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib50","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2017.4046","article-title":"Assessment of global kidney health care status","volume":"317","author":"Bello","year":"2017","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2018.02.007_bib51","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/01.ASN.0000093239.32602.04","article-title":"Renal replacement therapy in patients with diabetes and end-stage renal disease","volume":"15","author":"Locatelli","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2018.02.007_bib52","first-page":"Svii","article-title":"US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States","volume":"66","author":"Saran","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib53","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.2337\/dc12-2148","article-title":"Epidemiology and mortality of new-onset diabetes after dialysis: Taiwan national cohort study","volume":"36","author":"Tien","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib54","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2215\/CJN.08921010","article-title":"Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus","volume":"6","author":"Duong","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/sdi.12198","article-title":"Updates on the management of diabetes in dialysis patients","volume":"27","author":"Rhee","year":"2014","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib56","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/ki.1994.152","article-title":"Glucose oxidation after a peritoneal and an oral glucose load in dialyzed patients","volume":"45","author":"Delarue","year":"1994","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2018.02.007_bib57","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1177\/089686080502503S20","article-title":"The clinical and epidemiological aspects of vascular mortality in chronic peritoneal dialysis patients","volume":"25","author":"Li","year":"2005","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3747\/pdi.2013.00083","article-title":"High glucose concentrations in peritoneal dialysate are associated with all-cause and cardiovascular disease mortality in continuous ambulatory peritoneal dialysis patients","volume":"35","author":"Wen","year":"2015","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib59","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1159\/000128608","article-title":"Initial glucose load predicts technique survival in patients on chronic peritoneal dialysis","volume":"28","author":"Wu","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib60","doi-asserted-by":"crossref","first-page":"e30337","DOI":"10.1371\/journal.pone.0030337","article-title":"Safety issues of long-term glucose load in patients on peritoneal dialysis--a 7-year cohort study","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib61","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/ndt\/gfv247","article-title":"Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH)","volume":"30","author":"de Moraes","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib62","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1681\/ASN.2007101128","article-title":"Lipid abnormalities and cardiovascular risk in renal disease","volume":"19","author":"Ritz","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib63","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/sdi.12375","article-title":"Dyslipidemia in dialysis patients","volume":"28","author":"Qunibi","year":"2015","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib64","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1046\/j.1523-1755.63.s84.23.x","article-title":"Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients","volume":"84","author":"Kronenberg","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib65","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0272-6386(00)70255-1","article-title":"Atherogenic lipoprotein phenotype in end-stage renal failure: origin and extent of small dense low-density lipoprotein formation","volume":"35","author":"Deighan","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib66","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1046\/j.1523-1755.1999.00375.x","article-title":"Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis","volume":"55","author":"Attman","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1053\/j.ajkd.2003.09.012","article-title":"The effect of long-term aggressive lipid lowering on ischemic and atherosclerotic burden in patients with chronic kidney disease","volume":"43","author":"Fathi","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib68","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(12)70364-5","article-title":"Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities","volume":"15","author":"Lowrie","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib69","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","article-title":"Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients","volume":"58","author":"Cheung","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib70","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1046\/j.1523-1755.2002.00324.x","article-title":"Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients","volume":"61","author":"Iseki","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib71","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1093\/ndt\/gfl272","article-title":"The association of lipid levels with mortality in patients on chronic peritoneal dialysis","volume":"21","author":"Habib","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib72","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jama.291.4.451","article-title":"Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition","volume":"291","author":"Liu","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib73","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/j.ajkd.2007.07.023","article-title":"The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis","volume":"50","author":"Goldfarb-Rumyantzev","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib74","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib75","first-page":"CD004289","article-title":"HMG CoA reductase inhibitors (statins) for dialysis patients","volume":"9","author":"Palmer","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib76","article-title":"United States Renal Data System 2008 Annual Data Report","volume":"53 (Suppl:)","author":"Collins","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2018.02.007_bib77","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients","volume":"45","author":"Workgroup","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib78","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2014.31","article-title":"Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group M. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient","volume":"85","author":"Wanner","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib79","first-page":"1226","article-title":"Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib80","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.V113520","article-title":"Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD","volume":"11","author":"Longenecker","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib81","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.ajkd.2011.03.025","article-title":"Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity","volume":"58","author":"Liebman","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib82","doi-asserted-by":"crossref","first-page":"e114897","DOI":"10.1371\/journal.pone.0114897","article-title":"The association between body mass index and mortality in incident dialysis patients","volume":"9","author":"Badve","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib83","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib84","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2215\/CJN.06620613","article-title":"Metabolic syndrome in peritoneal dialysis patients: choice of diagnostic criteria and prognostic implications","volume":"9","author":"Szeto","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib85","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3747\/pdi.2013.00001","article-title":"Associations between serum-intact parathyroid hormone, serum 25-hydroxyvitamin D, oral vitamin D analogs and metabolic syndrome in peritoneal dialysis patients: a multi-center cross-sectional study","volume":"34","author":"Dong","year":"2014","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib86","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/nep.12124","article-title":"Effect of metabolic syndrome on clinical outcomes of non-diabetic peritoneal dialysis patients in India","volume":"18","author":"Prasad","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib87","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1046\/j.1523-1755.1999.00389.x","article-title":"Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients","volume":"55","author":"Fleischmann","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib88","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.ajkd.2011.03.023","article-title":"Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients","volume":"58","author":"Ricks","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib89","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/j.ajkd.2005.05.020","article-title":"Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population","volume":"46","author":"Kalantar-Zadeh","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib90","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/ajcn\/83.2.202","article-title":"Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients","volume":"83","author":"Kalantar-Zadeh","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib91","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/80.2.324","article-title":"Association of body size with outcomes among patients beginning dialysis","volume":"80","author":"Johansen","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib92","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pcad.2013.10.005","article-title":"Obesity paradox in end-stage kidney disease patients","volume":"56","author":"Park","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib93","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1525-139X.2007.00347.x","article-title":"Body mass index and peritoneal dialysis: \"exceptions to the exception\" in reverse epidemiology?","volume":"20","author":"Abbott","year":"2007","journal-title":"Semin Dial"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2018.02.007_bib94","doi-asserted-by":"crossref","first-page":"S250","DOI":"10.1177\/089686080702702s43","article-title":"What is the optimal fat mass in peritoneal dialysis patients?","volume":"27","author":"Johnson","year":"2007","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib95","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/089686080002000623","article-title":"Is obesity a favorable prognostic factor in peritoneal dialysis patients?","volume":"20","author":"Johnson","year":"2000","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib96","doi-asserted-by":"crossref","first-page":"51","DOI":"10.6061\/clinics\/2013(01)OA08","article-title":"Body size and longitudinal body weight changes do not increase mortality in incident peritoneal dialysis patients of the Brazilian peritoneal dialysis multicenter study","volume":"68","author":"Fernandes","year":"2013","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib97","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/089686080502500510","article-title":"Effect of body size and body composition on survival in peritoneal dialysis patients","volume":"25","author":"Ramkumar","year":"2005","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib98","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.ajkd.2004.12.013","article-title":"Association of physical activity with mortality in the US dialysis population","volume":"45","author":"Stack","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib99","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1440-1797.2008.01036.x","article-title":"Review article: Tackling the survival issue in end-stage renal disease: time to get physical on haemodialysis","volume":"13","author":"Cheema","year":"2008","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/ajkd.2003.50055","article-title":"Decreased survival among sedentary patients undergoing dialysis: results from the dialysis morbidity and mortality study wave 2","volume":"41","author":"O'Hare","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib101","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1681\/ASN.2016030378","article-title":"Exercise in patients on dialysis: a multicenter, randomized clinical trial","volume":"28","author":"Manfredini","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib102","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ki.2013.77","article-title":"Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies","volume":"84","author":"Palmer","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib103","doi-asserted-by":"crossref","first-page":"c29","DOI":"10.1159\/000314548","article-title":"Association between depression symptoms with inflammation and cardiovascular risk factors in patients undergoing peritoneal dialysis","volume":"116","author":"Ko","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib104","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.ajkd.2013.02.369","article-title":"Association between depression and death in people with CKD: a meta-analysis of cohort studies","volume":"62","author":"Palmer","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib105","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1523-1755.2004.00530.x","article-title":"Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression","volume":"65","author":"Zoccali","year":"2004","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2018.02.007_bib106","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.2215\/CJN.04860709","article-title":"Left ventricular mass in chronic kidney disease and ESRD","volume":"4","author":"Glassock","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 4","key":"10.1016\/j.semnephrol.2018.02.007_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nep.12642","article-title":"Anaemia and early phase cardiovascular events on haemodialysis","volume":"20","author":"Hayashi","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib108","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2215\/CJN.01050211","article-title":"Association of hemoglobin and survival in peritoneal dialysis patients","volume":"6","author":"Molnar","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib109","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/gfg458","article-title":"Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib110","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib111","article-title":"Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis","volume":"12","author":"Palmer","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib112","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ki.2014.425","article-title":"Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference","volume":"87","author":"Ketteler","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib113","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3747\/pdi.2013.00177","article-title":"Calcium balance and negative impact of calcium load in peritoneal dialysis patients","volume":"34","author":"Wang","year":"2014","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib114","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib115","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1053\/j.ajkd.2015.03.036","article-title":"Association of drug effects on serum parathyroid hormone, phosphorus, and calcium levels with mortality in CKD: a meta-analysis","volume":"66","author":"Palmer","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib116","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/j.ajkd.2016.05.015","article-title":"Phosphate-binding agents in adults with CKD: a network meta-analysis of randomized trials","volume":"68","author":"Palmer","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001436","article-title":"Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials","volume":"10","author":"Palmer","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib118","article-title":"Vitamin D compounds for people with chronic kidney disease requiring dialysis","volume":"4","author":"Palmer","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib119","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1440-1797.2009.01114.x","article-title":"Review article: Addressing risk factors in chronic kidney disease mineral and bone disorder: can we influence patient-level outcomes?","volume":"14","author":"O'Shea","year":"2009","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib120","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","article-title":"KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder (CKD-MBD)","volume":"55","author":"Uhlig","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib121","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2369-15-122","article-title":"Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies","volume":"15","author":"Li","year":"2014","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib122","first-page":"645","article-title":"Serum uric acid and C-reactive protein levels in patients with chronic kidney disease","volume":"25","author":"Caravaca","year":"2005","journal-title":"Nefrologia"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib123","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/ndt\/gft378","article-title":"Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis","volume":"29","author":"Bose","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"2-3","key":"10.1016\/j.semnephrol.2018.02.007_bib124","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000350143","article-title":"Uric acid levels and all-cause mortality in peritoneal dialysis patients","volume":"37","author":"Feng","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.ajkd.2013.08.027","article-title":"Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis","volume":"64","author":"Xia","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib126","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.2215\/CJN.00670111","article-title":"Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population","volume":"6","author":"Latif","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib127","first-page":"879","article-title":"Prognostic value of C-reactive protein for heart disease in dialysis patients","volume":"6","author":"Wang","year":"2005","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib128","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semnephrol.2011.01.005","article-title":"Consequences of chronic inflammation in peritoneal dialysis","volume":"31","author":"Wang","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib129","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1681\/ASN.V124814","article-title":"Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?","volume":"12","author":"Herzig","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib130","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1681\/ASN.2013030314","article-title":"Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival","volume":"24","author":"Lambie","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib131","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.ASN.0000135053.98172.D6","article-title":"Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients","volume":"15","author":"Wang","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib132","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.arcmed.2013.10.016","article-title":"Anti-inflammatory interventions in end-stage kidney disease: a randomized, double-blinded, controlled and crossover clinical trial on the use of pravastatin in continuous ambulatory peritoneal dialysis","volume":"44","author":"Cueto-Manzano","year":"2013","journal-title":"Arch Med Res"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib133","first-page":"423","article-title":"The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial. Benef Microbes","volume":"6","author":"Wang","year":"2015"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib134","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3747\/pdi.2009.00073","article-title":"Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study","volume":"30","author":"Nascimento","year":"2010","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib135","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0002-9149(97)00159-8","article-title":"Elevated soluble CD14 receptors and altered cytokines in chronic heart failure","volume":"79","author":"Anker","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib136","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3747\/pdi.2008.00242","article-title":"Endotoxemia is associated with better clinical outcome in incident Chinese peritoneal dialysis patients: a prospective cohort study","volume":"30","author":"Szeto","year":"2010","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib137","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1744-9987.2010.00815.x","article-title":"Low-grade endotoxemia contributes to chronic inflammation in hemodialysis patients: examination with a novel lipopolysaccharide detection method","volume":"14","author":"Terawaki","year":"2010","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib138","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2215\/CJN.04610510","article-title":"Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease","volume":"6","author":"McIntyre","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib139","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/sdi.12280","article-title":"Endotoxemia in end-stage kidney disease","volume":"28","author":"Wong","year":"2015","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib140","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1681\/ASN.2013080905","article-title":"The gut microbiome, kidney disease, and targeted interventions","volume":"25","author":"Ramezani","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib141","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ejheart.2003.12.004","article-title":"Selective intestinal decontamination in advanced chronic heart failure: a pilot trial","volume":"6","author":"Conraads","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib142","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0272-6386(99)70190-3","article-title":"Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance","volume":"33","author":"Diaz-Buxo","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib143","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1523-1755.2000.00184.x","article-title":"Peritoneal dialysis adequacy and risk of death","volume":"58","author":"Rocco","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib144","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/089686080002000411","article-title":"Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition","volume":"20","author":"Shemin","year":"2000","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib145","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/089686080202200312","article-title":"Risk factors for early mortality in U.S. peritoneal dialysis patients: impact of residual renal function","volume":"22","author":"Rocco","year":"2002","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib146","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/089686080402400106","article-title":"Independent effects of renal and peritoneal clearances on the mortality of peritoneal dialysis patients","volume":"24","author":"Szeto","year":"2004","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib147","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1523-1755.2000.00179.x","article-title":"Importance of dialysis adequacy in mortality and morbidity of chinese CAPD patients","volume":"58","author":"Szeto","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib148","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1046\/j.1523-1755.2001.060002767.x","article-title":"Effect of fluid and sodium removal on mortality in peritoneal dialysis patients","volume":"60","author":"Ates","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib149","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.V1351307","article-title":"Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial","volume":"13","author":"Paniagua","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib150","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0272-6386(03)00362-7","article-title":"The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD )-2","volume":"41","author":"Termorshuizen","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib151","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/ndt\/18.3.590","article-title":"Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients","volume":"18","author":"Chung","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib152","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/089686080902900609","article-title":"Peritoneal small solute clearance is nonlinearly related to patient survival in the Australian and New Zealand peritoneal dialysis patient populations","volume":"29","author":"Rumpsfeld","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib153","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.V12102158","article-title":"Group CPDS. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study","volume":"12","author":"Bargman","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib154","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/ndt\/10.12.2295","article-title":"Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study","volume":"10","author":"Maiorca","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000450690","article-title":"Evidence for Biocompatible Peritoneal Dialysis Solutions","volume":"189","author":"Nataatmadja","year":"2017","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib156","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2215\/CJN.05410514","article-title":"Effect of neutral-pH, low-glucose degradation product peritoneal dialysis solutions on residual renal function, urine volume, and ultrafiltration: a systematic review and meta-analysis","volume":"10","author":"Yohanna","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib157","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients","volume":"6","author":"Zhang","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib158","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12882-017-0605-7","article-title":"Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials","volume":"18","author":"Liu","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib159","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/ckj\/sfu140","article-title":"Strategies for preserving residual renal function in peritoneal dialysis patients","volume":"8","author":"Nongnuch","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib160","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.ki.5002585","article-title":"A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease","volume":"73","author":"Fouque","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib161","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1093\/ndt\/gfg318","article-title":"Is malnutrition an independent predictor of mortality in peritoneal dialysis patients?","volume":"18","author":"Chung","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib162","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000316682","article-title":"Malnutrition-inflammation score independently determined cardiovascular and infection risk in peritoneal dialysis patients","volume":"30","author":"Ho","year":"2010","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2018.02.007_bib163","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrneph.2010.68","article-title":"Cardiovascular risk in the peritoneal dialysis patient","volume":"6","author":"Krediet","year":"2010","journal-title":"Nat Rev Nephrol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929518300287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929518300287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T17:11:03Z","timestamp":1720285863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929518300287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":163,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0270929518300287"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2018.02.007","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Studies of Interventions to Mitigate Cardiovascular Risk in Peritoneal Dialysis Patients","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2018.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}